Evaluation of Safety & Efficacy of MIR 19 ® Inhalation Solution in Patients With Moderate COVID-19

Conditions

• COVID-19

Interventions

• DRUG: MIR 19 ®
• COMBINATION_PRODUCT: Standard COVID-19 therapy

Sponsor

National Research Center - Institute of Immunology Federal Medical-Biological Agency of Russia

Collaborators

• [object Object]